Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
501,650,900
-
Total 13F shares
-
409,336,032
-
Share change
-
+16,124,383
-
Total reported value
-
$11,420,444,049
-
Put/Call ratio
-
328%
-
Price per share
-
$27.93
-
Number of holders
-
341
-
Value change
-
+$507,354,498
-
Number of buys
-
175
-
Number of sells
-
174
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) as of Q3 2020
As of 30 Sep 2020,
Elanco Animal Health Inc - Common Stock (ELAN) was held by
341 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
409,336,032 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, PRIMECAP MANAGEMENT CO/CA/, Aristotle Capital Management, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, NOMURA HOLDINGS INC, STATE STREET CORP, and UBS Group AG.
This page lists
344
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.